Shanghai Kehua Bio-Engineering Co 002022.SZ · CNY

Its shares trade on Shenzhen under the ticker 002022.SZ. It has been listed since 21 July 2004. In the fiscal year to 31 December 2025, it reported revenue of CN¥1.64bn and a net loss of CN¥732.1m. At that date it held total assets of CN¥4.64bn and shareholders' equity of CN¥2.64bn.

Shanghai Kehua Bio-Engineering Co., Ltd. engages in the research, development, manufacture, and marketing business operation covering the whole industrial chain of vitro diagnostic device (IVD). The company is headquartered in Shanghai, Shanghai. The company went IPO on 2004-07-21. The firm's products include in vitro diagnostic reagents, medical instruments and vacuum blood drawing supplies, among others. The firm operates its businesses in both domestic and overseas markets, with China as its main market.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Ming LiChairman of the Board, President, since 2023CN¥2.0m
• Mr. Zhichao MaVice Chairman of the Board, since 2022
• Ms. Fang LuoChief Financial OfficerCN¥1.4m
• Ms. Chao ChenSenior Vice President, since 2020CN¥2.5m
• Ms. Hongying JinVice President, Secretary of the Board, Director, since 2022CN¥1.1m
• Mr. Jiaming LiangVice President, Director, since 2023CN¥894,800
• Mr. Baogang MiaoVice President, Director, since 2023CN¥1.8m
• Mr. Hyuk Shin KangVice PresidentCN¥403,800
• Mr. Niancai PengDirector
• Mr. Wenhua ShanIndependent Director
• Mr. Zhenxi ZhangIndependent Director
• Mr. Chuanfang ZhengIndependent DirectorCN¥75,000

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.